Women with breast cancer who took aspirin regularly before being diagnosed with the condition are less likely to see the illness spread to other parts of the body.

On Tuesday researchers revealed that aspirin — the little white pill we all take for granted — could be a breakthrough medicine in the fight against cancer. But with serious health risks also linked to its long-term use, what do the findings really mean? Fiachra Ó Cionnaith reports

Women who stop taking breast cancer drugs because of unbearable side-effects are almost three times more likely to have their cancer return.

RESEARCHERS in Trinity College Dublin (TCD) have discovered that blocking a particular stress response can significantly reduce the spread of breast cancer.